Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
GNTA stock closed with a significant jump of 21.40% today, reaching $6.92 at the closing bell. This surge was fueled by exciting...
